Medicure
Clinical trials sponsored by Medicure, explained in plain language.
Medicure
MPH
TSX VENTURE
Pharmaceutical company focused on cardiovascular drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for kids with rare seizure disorder: vitamin B6 therapy in final testing phase Results expected Nov 2026 (estimated) 🚀 Make-or-break